Drug discovery

#Clinical trial design #Clinical trials #Drug development #Drug discovery

Is disclosure non-compliance harming drug development?

Ali Pashazadeh, Founder and CEO of Treehill Partners, explores how clinical trial disclosure non-compliance is placing major pressures on clinical development, biopharma investment, and patient access to life saving therapies. Clinical trial disclosure non-compliance is rarely discussed and often ignored as a problem in the drug development sector. It is,… Read More

#Exclusive Content

#Clinical trials #Drug delivery #Drug discovery #Patient centricity

Patient-centric clinical trials: Prescription for better health outcomes 

Kimberly Gentile​, Senior Vice President of Clinical Operations at Biohaven Pharmaceuticals, explores the importance of newer patient-centric clinical trial strategies that can help enable better outcomes.   Drug development is my passion. My 30-year career in the pharmaceutical industry has been spent on the frontline of… Read More

#Exclusive Content

#Biopharma #Digitalisation #Drug development #Drug discovery

How “digitally mature” is your pharma company? 

By Craig Williamson, Lead Platform Product Manager, Integrations Strategy at IDBS.   The biopharma industry is changing. Companies with mature digital approaches are achieving operational efficiencies and breakthroughs in R&D. Companies that don’t risk being left behind.   Digital maturity is not just about… Read More

#Exclusive Content

Blood samples in lab
#Drug discovery #Indivumed Therapeutics #Molecular Biology #Oncology #Sample preparation

Fast changes within tumour samples could mislead researchers

Significant changes in the molecular characteristics of tumour samples occur within as little as 10 minutes after surgical removal, a new study led by Indivumed Therapeutics has revealed. The findings underline the importance of rapid snap freezing of tissue samples to reliably capture cancer biology and… Read More

#Cancer Research #News

#Drug discovery

Technical Note: EtoxiClear®: Optimizing endotoxin removal

In this technical note you will learn more about: Targeted and efficient endotoxin removal: EtoxiClear® is a highly effective chromatography affinity adsorbent, specifically designed to remove low residual levels of endotoxins across a variety of biopharmaceutical processes, ensuring high product purity Scalability and cost-effectiveness: Designed for both small and large-scale… Read More

#Technical Notes

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug discovery #Neuroscience

The latest advancements driving neuroscience drug discovery research

In this webinar, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Dr Klein shares how Dewpoint applies insights into… Read More

Webinar date:
Supported by Apconix
#Webinars

#Drug discovery

Smart note: Reduce costs, while continuing to safeguard samples, by raising the setpoint for ULT freezers from –80°C to –70°C

Download this smart note to learn more about: Energy savings: Discover how setting your Thermo Scientific™ TSX™ Universal Series ULT freezers to –70°C can help reduce energy consumption by up to 37% Sample integrity: Learn why most biological samples, including crucial nucleic acids, bacteria, and viruses, remain stable at –70°C… Read More

#Smart Notes

#Drug development #Drug discovery #Drug technology #Neuroscience #Webinar

Watch DDW’s first Neuroscience Showcase

In this free online event at 3pm BST on 24 October, hosted by DDW and sponsored by ApconiX and AxoSim, leading industry figures outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector. The showcase includes a panel… Read More

Webinar date:
Co-sponsored by ApconiX and AxoSim
#News

#Drug development #Drug discovery #Drug technology #Neuroscience

Neuroscience Showcase

In this free online event, hosted by DDW and sponsored by ApconiX and AxoSim, leading industry figures will outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector. The showcase will include a panel discussion looking at the use of new drug discovery and development… Read More

Webinar date:
Sponsored by ApconiX and AxoSim
#Webinars

Neuroscience innovation
#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

Last chance: Driving neuroscience drug discovery research

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News

#Artificial intelligence (AI) #Drug discovery

DDW eReport: AI and ML: How technology is improving drug discovery

Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free In Focus report available to download now. Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can… Read More

#DDW In Focus eReports

The Royal College of Physicians Edinburgh
#Drug discovery #ELRIG #Events #Scotland

Drug discovery innovation in Scotland, the home of invention

Diana Spencer reports on ELRIG UK’s Drug Discovery in Scotland Forum, held in the grandiose surroundings of the Royal College of Physicians Edinburgh in September. The Drug Discovery in Scotland Forum showcased how Scotland is shaping drug discovery using approaches including traditional small molecules, therapeutic proteins,… Read More

#Exclusive Content

Microbiome
#Drug development #Drug discovery #Mental health #Microbiome #Oncology

Hot off the press: Read the Fall issue of DDW now

The DDW Fall issue is out now and asks if the gut microbiome can unlock new therapeutics for mental health disorders, places a spotlight on oncology and includes a market report on the North American drug discovery hotspots. It also features an exclusive guide on… Read More

#Editor's Choice #News

#Drug discovery

Webinar: Building advanced cell models for toxicity testing – Lonza – 19.09.2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are all important for supporting preclinical and clinical pharmaceutical workflows for drug discovery and absorption, distribution, metabolism, excretion, and toxicity (ADMET)… Read More

#Webinars